August 3, 2007 – Novation, a healthcare contracting and services company of VHA Inc. and the University HealthSystem Consortium (UHC), awarded ev3 Inc. three, three-year contracts beginning Oct.

August 3, 2007 - Volcano Corp. announced it has received approval by regulatory authorities in Japan to market the Revolution 45 MHz rotational IVUS imaging catheter and related accessories, which covers the use of the Revolution Catheter when used on Volcano's IVG IVUS system, and will be the highest frequency IVUS catheter available in key Japanese market.
Volcano, which is already shipping the Revolution catheter in the U.S. and Europe, expects to launch the Revolution catheter into Japan in the fourth quarter of this year.

August 3, 2007 - CryoCor Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced today that the FDA has granted pre-market approval (PMA) for its Cardiac Cryoablation System for the treatment of right atrial flutter, enabling CryoCor to target over 200,000 U.S. patients treating flutter with cryoablation annually.

August 2, 2007 — Siemens Medical Solutions Diagnostics announced the availability of the ADVIA 1800 chemistry system, which features an intuitive software interface and advanced chemistry testing capabilities to deliver optimized performance and reliable results, according to manufacturer.

August 1, 2007 - SonoSite Inc., a developer of portable ultrasound, announced it has acquired LumenVu Inc., a company that has developed a patented technology to improve the accuracy of catheter placement, as part of SonoSite’s strategy to strengthen its position in the vascular access market and add the disposable catheter guidance device sector as a new revenue stream.
While specifics of the deal were not disclosed, SonoSite plans to introduce products based on this technology in late 2008.

August 1, 2007 - Positron Corp. announced that a recent study by The State University of New York at Buffalo reveals that Positron Emission Tomography (PET) scanning when used as the first tool to diagnose heart-vessel blockages, is more accurate, less invasive and cost effective than SPECT imaging.

August 1, 2007 - BioControl Medical announced that cardiologists at University Hospital Mannheim in Germany and at Ospedali Riuniti di Bergamo in Italy have successfully implanted the CardioFit device in the first patients to be enrolled at those sites in BioControl’s international, multi-center clinical study of the CardioFit system, marking an important step for the treatment of advanced conge

August 1, 2007 - AGA Medical Corp. (AGA), owner of a European patent (EP 0 808 138) for intravascular occlusion devices and the method of forming or manufacturing these medical devices, announced that it has won its patent infringement lawsuit against Occlutech GmbH and DRABO Medizintechnik.

July 31, 2007 - Implantable defibrillators can reduce the risk of sudden death in high-risk patients with hypertrophic cardiomyopathy, according to a new study conducted at the Hypertrophic Cardiomyopathy Center at the Minneapolis Heart Institute Foundation and published in the July 25 issue of the Journal of the American Medical Association.

July 31, 2007 - GlaxoSmithKline announced the recommendation of an FDA advisory committee to support Avandia’s (rosiglitazone maleate), an oral anti-diabetic medicine, continued availability to patients in the U.S., information which the FDA will consider its final decision-making process.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now